SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-22-152368
Filing Date
2022-05-17
Accepted
2022-05-17 06:06:59
Documents
1

Document Format Files

Seq Description Document Type Size
1 DEFA14A d350043ddefa14a.htm DEFA14A 15181
  Complete submission text file 0001193125-22-152368.txt   16239
Mailing Address 18706 NORTH CREEK PARKWAY, SUITE 104 BOTHELL WA 98011
Business Address 18706 NORTH CREEK PARKWAY, SUITE 104 BOTHELL WA 98011 (425) 620-8501
Athira Pharma, Inc. (Filer) CIK: 0001620463 (see all company filings)

IRS No.: 453368487 | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-39503 | Film No.: 22932149
SIC: 2836 Biological Products, (No Diagnostic Substances)